Memory Inflation Drives Tissue-Resident Memory CD8+ T Cell Maintenance in the Lung After Intranasal Vaccination With Murine Cytomegalovirus

Tissue-resident memory T (TRM) cells provide first-line defense against invading pathogens encountered at barrier sites. In the lungs, TRM cells protect against respiratory infections, but wane more quickly than TRM cells in other tissues. This lack of a sustained TRM population in the lung parenchy...

Full description

Bibliographic Details
Main Authors: Kaitlyn M. Morabito, Tracy J. Ruckwardt, Erez Bar-Haim, Deepika Nair, Syed M. Moin, Alec J. Redwood, David A. Price, Barney S. Graham
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-08-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fimmu.2018.01861/full
_version_ 1828786901769781248
author Kaitlyn M. Morabito
Kaitlyn M. Morabito
Tracy J. Ruckwardt
Erez Bar-Haim
Erez Bar-Haim
Deepika Nair
Syed M. Moin
Alec J. Redwood
David A. Price
David A. Price
Barney S. Graham
author_facet Kaitlyn M. Morabito
Kaitlyn M. Morabito
Tracy J. Ruckwardt
Erez Bar-Haim
Erez Bar-Haim
Deepika Nair
Syed M. Moin
Alec J. Redwood
David A. Price
David A. Price
Barney S. Graham
author_sort Kaitlyn M. Morabito
collection DOAJ
description Tissue-resident memory T (TRM) cells provide first-line defense against invading pathogens encountered at barrier sites. In the lungs, TRM cells protect against respiratory infections, but wane more quickly than TRM cells in other tissues. This lack of a sustained TRM population in the lung parenchyma explains, at least in part, why infections with some pathogens, such as influenza virus and respiratory syncytial virus (RSV), recur throughout life. Intranasal (IN) vaccination with a murine cytomegalovirus (MCMV) vector expressing the M protein of RSV (MCMV-M) has been shown to elicit robust populations of CD8+ TRM cells that accumulate over time and mediate early viral clearance. To extend this finding, we compared the inflationary CD8+ T cell population elicited by MCMV-M vaccination with a conventional CD8+ T cell population elicited by an MCMV vector expressing the M2 protein of RSV (MCMV-M2). Vaccination with MCMV-M2 induced a population of M2-specific CD8+ TRM cells that waned rapidly, akin to the M2-specific CD8+ TRM cell population elicited by infection with RSV. In contrast to the natural immunodominance profile, however, coadministration of MCMV-M and MCMV-M2 did not suppress the M-specific CD8+ T cell response, suggesting that progressive expansion was driven by continuous antigen presentation, irrespective of the competitive or regulatory effects of M2-specific CD8+ T cells. Moreover, effective viral clearance mediated by M-specific CD8+ TRM cells was not affected by the coinduction of M2-specific CD8+ T cells. These data show that memory inflation is required for the maintenance of CD8+ TRM cells in the lungs after IN vaccination with MCMV.
first_indexed 2024-12-12T00:19:45Z
format Article
id doaj.art-c945c838557b41e79f92598e2bdcbe96
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-12-12T00:19:45Z
publishDate 2018-08-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-c945c838557b41e79f92598e2bdcbe962022-12-22T00:44:45ZengFrontiers Media S.A.Frontiers in Immunology1664-32242018-08-01910.3389/fimmu.2018.01861378605Memory Inflation Drives Tissue-Resident Memory CD8+ T Cell Maintenance in the Lung After Intranasal Vaccination With Murine CytomegalovirusKaitlyn M. Morabito0Kaitlyn M. Morabito1Tracy J. Ruckwardt2Erez Bar-Haim3Erez Bar-Haim4Deepika Nair5Syed M. Moin6Alec J. Redwood7David A. Price8David A. Price9Barney S. Graham10Viral Pathogenesis Laboratory, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United StatesDepartment of Microbiology and Immunology, Georgetown University Medical Center, Washington, DC, United StatesViral Pathogenesis Laboratory, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United StatesViral Pathogenesis Laboratory, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United StatesDepartment of Biochemistry and Molecular Genetics, Israel Institute for Biological Research, Ness-Ziona, IsraelViral Pathogenesis Laboratory, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United StatesViral Pathogenesis Laboratory, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United StatesInstitute for Immunology and Infectious Diseases, Murdoch University, Perth, WA, AustraliaDivision of Infection and Immunity, Cardiff University School of Medicine, Cardiff, United KingdomHuman Immunology Section, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United StatesViral Pathogenesis Laboratory, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United StatesTissue-resident memory T (TRM) cells provide first-line defense against invading pathogens encountered at barrier sites. In the lungs, TRM cells protect against respiratory infections, but wane more quickly than TRM cells in other tissues. This lack of a sustained TRM population in the lung parenchyma explains, at least in part, why infections with some pathogens, such as influenza virus and respiratory syncytial virus (RSV), recur throughout life. Intranasal (IN) vaccination with a murine cytomegalovirus (MCMV) vector expressing the M protein of RSV (MCMV-M) has been shown to elicit robust populations of CD8+ TRM cells that accumulate over time and mediate early viral clearance. To extend this finding, we compared the inflationary CD8+ T cell population elicited by MCMV-M vaccination with a conventional CD8+ T cell population elicited by an MCMV vector expressing the M2 protein of RSV (MCMV-M2). Vaccination with MCMV-M2 induced a population of M2-specific CD8+ TRM cells that waned rapidly, akin to the M2-specific CD8+ TRM cell population elicited by infection with RSV. In contrast to the natural immunodominance profile, however, coadministration of MCMV-M and MCMV-M2 did not suppress the M-specific CD8+ T cell response, suggesting that progressive expansion was driven by continuous antigen presentation, irrespective of the competitive or regulatory effects of M2-specific CD8+ T cells. Moreover, effective viral clearance mediated by M-specific CD8+ TRM cells was not affected by the coinduction of M2-specific CD8+ T cells. These data show that memory inflation is required for the maintenance of CD8+ TRM cells in the lungs after IN vaccination with MCMV.https://www.frontiersin.org/article/10.3389/fimmu.2018.01861/fullCD8+ T cellscytomegalovirusmemory inflationrespiratory syncytial virustissue-resident memoryvaccine
spellingShingle Kaitlyn M. Morabito
Kaitlyn M. Morabito
Tracy J. Ruckwardt
Erez Bar-Haim
Erez Bar-Haim
Deepika Nair
Syed M. Moin
Alec J. Redwood
David A. Price
David A. Price
Barney S. Graham
Memory Inflation Drives Tissue-Resident Memory CD8+ T Cell Maintenance in the Lung After Intranasal Vaccination With Murine Cytomegalovirus
Frontiers in Immunology
CD8+ T cells
cytomegalovirus
memory inflation
respiratory syncytial virus
tissue-resident memory
vaccine
title Memory Inflation Drives Tissue-Resident Memory CD8+ T Cell Maintenance in the Lung After Intranasal Vaccination With Murine Cytomegalovirus
title_full Memory Inflation Drives Tissue-Resident Memory CD8+ T Cell Maintenance in the Lung After Intranasal Vaccination With Murine Cytomegalovirus
title_fullStr Memory Inflation Drives Tissue-Resident Memory CD8+ T Cell Maintenance in the Lung After Intranasal Vaccination With Murine Cytomegalovirus
title_full_unstemmed Memory Inflation Drives Tissue-Resident Memory CD8+ T Cell Maintenance in the Lung After Intranasal Vaccination With Murine Cytomegalovirus
title_short Memory Inflation Drives Tissue-Resident Memory CD8+ T Cell Maintenance in the Lung After Intranasal Vaccination With Murine Cytomegalovirus
title_sort memory inflation drives tissue resident memory cd8 t cell maintenance in the lung after intranasal vaccination with murine cytomegalovirus
topic CD8+ T cells
cytomegalovirus
memory inflation
respiratory syncytial virus
tissue-resident memory
vaccine
url https://www.frontiersin.org/article/10.3389/fimmu.2018.01861/full
work_keys_str_mv AT kaitlynmmorabito memoryinflationdrivestissueresidentmemorycd8tcellmaintenanceinthelungafterintranasalvaccinationwithmurinecytomegalovirus
AT kaitlynmmorabito memoryinflationdrivestissueresidentmemorycd8tcellmaintenanceinthelungafterintranasalvaccinationwithmurinecytomegalovirus
AT tracyjruckwardt memoryinflationdrivestissueresidentmemorycd8tcellmaintenanceinthelungafterintranasalvaccinationwithmurinecytomegalovirus
AT erezbarhaim memoryinflationdrivestissueresidentmemorycd8tcellmaintenanceinthelungafterintranasalvaccinationwithmurinecytomegalovirus
AT erezbarhaim memoryinflationdrivestissueresidentmemorycd8tcellmaintenanceinthelungafterintranasalvaccinationwithmurinecytomegalovirus
AT deepikanair memoryinflationdrivestissueresidentmemorycd8tcellmaintenanceinthelungafterintranasalvaccinationwithmurinecytomegalovirus
AT syedmmoin memoryinflationdrivestissueresidentmemorycd8tcellmaintenanceinthelungafterintranasalvaccinationwithmurinecytomegalovirus
AT alecjredwood memoryinflationdrivestissueresidentmemorycd8tcellmaintenanceinthelungafterintranasalvaccinationwithmurinecytomegalovirus
AT davidaprice memoryinflationdrivestissueresidentmemorycd8tcellmaintenanceinthelungafterintranasalvaccinationwithmurinecytomegalovirus
AT davidaprice memoryinflationdrivestissueresidentmemorycd8tcellmaintenanceinthelungafterintranasalvaccinationwithmurinecytomegalovirus
AT barneysgraham memoryinflationdrivestissueresidentmemorycd8tcellmaintenanceinthelungafterintranasalvaccinationwithmurinecytomegalovirus